Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1564747164;47165;47166 chr2:178618611;178618610;178618609chr2:179483338;179483337;179483336
N2AB1400642241;42242;42243 chr2:178618611;178618610;178618609chr2:179483338;179483337;179483336
N2A1307939460;39461;39462 chr2:178618611;178618610;178618609chr2:179483338;179483337;179483336
N2B658219969;19970;19971 chr2:178618611;178618610;178618609chr2:179483338;179483337;179483336
Novex-1670720344;20345;20346 chr2:178618611;178618610;178618609chr2:179483338;179483337;179483336
Novex-2677420545;20546;20547 chr2:178618611;178618610;178618609chr2:179483338;179483337;179483336
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-108
  • Domain position: 80
  • Structural Position: 168
  • Q(SASA): 0.3514
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/V rs749085231 0.758 1.0 N 0.853 0.659 0.640954352468 gnomAD-2.1.1 4.04E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.91E-06 0
E/V rs749085231 0.758 1.0 N 0.853 0.659 0.640954352468 gnomAD-4.0.0 1.5949E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86374E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1955 likely_benign 0.254 benign -0.566 Destabilizing 0.999 D 0.69 prob.neutral N 0.517121857 None None N
E/C 0.8839 likely_pathogenic 0.928 pathogenic -0.451 Destabilizing 1.0 D 0.842 deleterious None None None None N
E/D 0.2146 likely_benign 0.2769 benign -0.86 Destabilizing 0.999 D 0.485 neutral N 0.518417153 None None N
E/F 0.8068 likely_pathogenic 0.8686 pathogenic 0.213 Stabilizing 1.0 D 0.863 deleterious None None None None N
E/G 0.3205 likely_benign 0.397 ambiguous -0.918 Destabilizing 1.0 D 0.789 deleterious N 0.519864475 None None N
E/H 0.5369 ambiguous 0.6337 pathogenic 0.259 Stabilizing 1.0 D 0.715 prob.delet. None None None None N
E/I 0.4199 ambiguous 0.5294 ambiguous 0.39 Stabilizing 1.0 D 0.877 deleterious None None None None N
E/K 0.2165 likely_benign 0.2641 benign -0.26 Destabilizing 0.999 D 0.584 neutral N 0.51446667 None None N
E/L 0.5509 ambiguous 0.6984 pathogenic 0.39 Stabilizing 1.0 D 0.86 deleterious None None None None N
E/M 0.538 ambiguous 0.6402 pathogenic 0.531 Stabilizing 1.0 D 0.834 deleterious None None None None N
E/N 0.3487 ambiguous 0.4351 ambiguous -0.951 Destabilizing 1.0 D 0.757 deleterious None None None None N
E/P 0.9385 likely_pathogenic 0.9607 pathogenic 0.093 Stabilizing 1.0 D 0.85 deleterious None None None None N
E/Q 0.1721 likely_benign 0.2059 benign -0.788 Destabilizing 1.0 D 0.64 neutral N 0.516465873 None None N
E/R 0.3764 ambiguous 0.4439 ambiguous 0.16 Stabilizing 1.0 D 0.759 deleterious None None None None N
E/S 0.2097 likely_benign 0.2576 benign -1.177 Destabilizing 0.999 D 0.641 neutral None None None None N
E/T 0.2008 likely_benign 0.2528 benign -0.871 Destabilizing 1.0 D 0.84 deleterious None None None None N
E/V 0.2327 likely_benign 0.3101 benign 0.093 Stabilizing 1.0 D 0.853 deleterious N 0.519864475 None None N
E/W 0.9254 likely_pathogenic 0.9536 pathogenic 0.517 Stabilizing 1.0 D 0.844 deleterious None None None None N
E/Y 0.7376 likely_pathogenic 0.8197 pathogenic 0.49 Stabilizing 1.0 D 0.859 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.